Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$93.95
Market cap
$2.11B
P/E Ratio
50.51
Dividend/share
$0.64
EPS
$1.86
Enterprise value
$2.11B
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops,
Highlights
LMAT's net income has soared by 52% year-on-year and by 10% since the previous quarter
The EPS has soared by 51% YoY and by 9% from the previous quarter
LMAT's quick ratio is up by 28% YoY but it is down by 6% QoQ
The P/E is 16% more than the 5-year quarterly average of 43.1 and 8% more than the last 4 quarters average of 45.9
The company's debt rose by 9% YoY
Key stats
What are the main financial stats of LMAT
Market
Valuations
Earnings
Shares outstanding
22.48M
Market cap
$2.11B
Enterprise value
$2.11B
Price to earnings (P/E)
50.51
Price to book (P/B)
6.38
Price to sales (P/S)
9.91
EV/EBIT
38.95
EV/EBITDA
33.07
EV/Sales
9.9
Revenue
$213.03M
Gross profit
$145.58M
Net income
$41.32M
EBIT
$54.17M
EBITDA
$63.8M
Free cash flow
$33.49M
Per share
Balance sheet
Liquidity
EPS
$1.86
EPS diluted
$1.82
Free cash flow per share
$1.49
Book value per share
$14.73
Revenue per share
$9.48
TBVPS
$12.18
Total assets
$377.03M
Total liabilities
$45.95M
Debt
$18.33M
Equity
$331.07M
Working capital
$197.77M
Debt to equity
0.06
Current ratio
7.74
Quick ratio
5.32
Net debt/EBITDA
-0.04
Margins
Efficiency
Dividend
EBITDA margin
29.9%
Gross margin
68.3%
Net margin
19.4%
Operating margin
23.3%
Return on assets
11.5%
Return on equity
13.1%
Return on invested capital
24.4%
Return on capital employed
15.6%
Return on sales
25.4%
Dividend yield
0.68%
DPS
$0.64
Payout ratio
34.4%
LMAT stock price
How has the Lemaitre Vascular stock price performed over time
Intraday
1.43%
1 week
1.84%
1 month
-10.88%
1 year
63.36%
YTD
65.52%
QTD
1.14%
Financial performance
How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$213.03M
Gross profit
$145.58M
Operating income
$49.61M
Net income
$41.32M
Gross margin
68.3%
Net margin
19.4%
LMAT's net income has soared by 52% year-on-year and by 10% since the previous quarter
The operating income has grown by 48% YoY and by 9% from the previous quarter
The company's net margin rose by 32% YoY and by 6% QoQ
The company's operating margin rose by 29% YoY and by 5% QoQ
Growth
What is Lemaitre Vascular's growth rate over time
Valuation
What is Lemaitre Vascular stock price valuation
P/E
50.51
P/B
6.38
P/S
9.91
EV/EBIT
38.95
EV/EBITDA
33.07
EV/Sales
9.9
The EPS has soared by 51% YoY and by 9% from the previous quarter
The P/E is 16% more than the 5-year quarterly average of 43.1 and 8% more than the last 4 quarters average of 45.9
LMAT's price to book (P/B) is 37% higher than its 5-year quarterly average of 4.6 and 19% higher than its last 4 quarters average of 5.3
The equity has grown by 15% YoY and by 3.6% from the previous quarter
The P/S is 42% above the 5-year quarterly average of 6.9 and 19% above the last 4 quarters average of 8.2
Lemaitre Vascular's revenue has increased by 15% YoY and by 3.6% from the previous quarter
Efficiency
How efficient is Lemaitre Vascular business performance
Lemaitre Vascular's return on assets has increased by 35% YoY and by 6% QoQ
The ROE has grown by 34% YoY and by 6% from the previous quarter
The ROS has grown by 31% YoY and by 6% from the previous quarter
LMAT's ROIC is up by 24% year-on-year and by 3.8% since the previous quarter
Dividends
What is LMAT's dividend history
DPS
$0.64
Dividend yield
0.68%
Payout ratio
34.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Lemaitre Vascular financials performed over time
LMAT's quick ratio is up by 28% YoY but it is down by 6% QoQ
Lemaitre Vascular's current ratio has increased by 23% YoY but it has decreased by 7% from the previous quarter
The company's debt is 94% lower than its equity
The equity has grown by 15% YoY and by 3.6% from the previous quarter
The company's debt rose by 9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.